Skip to main content

Drug Repurposing Market to Eyewitness Huge Growth by 2027 : Allergan, Astellas Pharma, Biovista, NuMedii

By: SBWire

NJ New Jersey, USA -- (SBWIRE) -- 11/07/2022 -- Advance Market Analytics published a new research publication on "Drug Repurposing Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Drug Repurposing market was mainly driven by the increasing R&D spending across the world.

Get Free Exclusive PDF Sample Copy of This Research @

Some of the key players profiled in the study are: Astellas Pharma Inc.(Japan), Biovista (United States), Novartis AG(Switzerland), AbbVie Inc. (United States), Pfizer Inc. (United States), Allergan Plc. (Ireland), NuMedii (United States), Recursion Pharmaceuticals (United States), Leiden University Medical(Netherlands), Linguamatics (United Kingdom).

Scope of the Report of Drug Repurposing
In recent years, many pharmaceutical corporations are producing new medicines with the development of novel biological targets by applying the drug repositioning strategy in drug discovery and development program. Developing a new drug is costly and time-consuming and drug repurposing comes forth as an excellent alternative, Drug Repurposing act as recycling is the act of taking drug intended to treat one patient population and demonstrating its efficacy in the treatment of a completely different group of patients. This approach is very efficient, time-saving, low-cost and least risk of failure. It maximizes the healing value of medicine and consequently improves the success rate. Drug Repurposing is an effective strategy in discovering or developing drug molecules with new pharmacological/therapeutic indications. Thus, the rise in the demand for drug repurposing is used as an effective alternative approach to the traditional drug discovery process.

The titled segments and sub-section of the market are illuminated below:
by Type (De novo drug discovery, Personalized Medicine, Genomics, Gene Editing), Methodology (Network-based approaches, Text mining approaches, Semantic approaches), Development Steps (Compound Identification, Compound Acquisition, Development, FDA Post Market safety monitoring)

Market Trends:
Increasing market demand many pharmaceutical companies are developing new drugs or new therapeutic uses from existing/old/available drugs by drug repositioning approaches in less time, yet at low cost.
The research and funding support

Drug Repurposing has several advantages in comparison with traditional approaches to drug discovery. When comparing with traditional drug discovery program, a significant reduction of the time spent in R&D can be observed and booming the growth opportunities

Market Drivers:
The rise of repositioning with the increasing pharma involvement as development progresses
The need for the low investment in terms of time and money is fuelling demand for drug repurposing which is leading to the increasing number of pipeline products is propelling the growth of the drug repurposing market.

Have Any Questions Regarding Global Drug Repurposing Market Report, Ask Our Experts@

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Strategic Points Covered in Table of Content of Global Drug Repurposing Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Drug Repurposing market
Chapter 2: Exclusive Summary – the basic information of the Drug Repurposing Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Drug Repurposing
Chapter 4: Presenting the Drug Repurposing Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020
Chapter 6: Evaluating the leading manufacturers of the Drug Repurposing market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2027)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

finally, Drug Repurposing Market is a valuable source of guidance for individuals and companies.

Read Detailed Index of full Research Study at @

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.

For more information on this press release visit:

Media Relations Contact

Praveen Kumar
PR & Marketing Manager
AMA Research & Media LLP
Telephone: +15513331547
Email: Click to Email Praveen Kumar

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.